Jefferies Sees Nearly 100% Upside in Synta Pharma. (SNTA)
Tweet Send to a Friend
Jefferies doubled its price target on Synta Pharma. (NASDAQ: SNTA) from $7 to $14 ahead of GALAXY Interim Data.
This article: 135 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 135 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE